High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.
Open Access
- 1 March 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (8) , 1006-1011
- https://doi.org/10.1161/01.CIR.0000156503.62815.48
Abstract
Background— We have previously shown that angiotensin II type 2 receptor (AT 2 R) stimulation causes endothelium-dependent vasodilation that does not desensitize after chronic angiotensin II type 1 receptor (AT 1 R) blockade, suggesting a role for AT 2 R in antihypertensive treatment. Methods and Results— We recorded mean arterial pressure (MAP) and investigated AT 2 R by Western blot analysis, immunohistochemistry, and function in isolated mesenteric resistance arteries (205 μm in diameter) from Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) receiving the following for 4 weeks in drinking water: placebo, AT 1 R blockade (candesartan; 2 mg/kg per day), ACE inhibitor (perindopril; 3 mg/kg per day), nonselective vasodilator (hydralazine; 16 or 24 mg/kg per day), or candesartan plus hydralazine (16 mg/kg per day). In precontracted isolated arteries, AT 2 R stimulation (angiotensin II in the presence of candesartan) caused vasodilation in WKY rats (MAP=118 mm Hg) and vasoconstriction in SHR (MAP=183 mm Hg). In SHR treated with candesartan (MAP=146 mm Hg) or hydralazine (16 mg/kg per day; MAP=145 mm Hg), AT 2 R-induced contraction was reduced by 50%. In SHR treated with perindopril (MAP=125 mm Hg), AT 2 R stimulation induced vasodilation. In SHR treated with hydralazine (24 mg/kg per day; MAP=105 mm Hg) and in SHR treated with hydralazine (16 mg/kg per day) plus candesartan (MAP=102 mm Hg), an AT 2 R-mediated vasodilation was restored. Immunochemistry and Western blot analysis showed that AT 2 R expression, lower in SHR than in WKY rats, was restored to normal levels by treatments reducing arterial pressure in SHR. Conclusions— Our results suggest that in resistance arteries of SHR, (1) AT 2 R is downregulated by hypertension, and (2) specific and nonspecific antihypertensive treatments restore AT 2 R expression and vasodilator functions.Keywords
This publication has 30 references indexed in Scilit:
- Differential regulation by AT1 and AT2 receptors of angiotensin II‐stimulated cyclic GMP production in rat uterine artery and aortaBritish Journal of Pharmacology, 2004
- Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideBritish Journal of Pharmacology, 2003
- Angiotensin AT2 receptors: cardiovascular hope or hype?British Journal of Pharmacology, 2003
- Angiotensin II Relaxes Microvessels Via the AT 2 Receptor and Ca 2+ -Activated K + (BK Ca ) ChannelsHypertension, 2001
- T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisJournal of Clinical Investigation, 2000
- Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive ratsBritish Journal of Pharmacology, 2000
- Activation of AT 2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance ArteriesHypertension, 1999
- Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor StimulationHypertension, 1995
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989